Dashboard
1
With a growth in Net Profit of 144.92%, the company declared Outstanding results in Sep 25
- The company has declared positive results for the last 6 consecutive quarters
- PRE-TAX PROFIT(Q) At CNY 38.49 MM has Grown at 271.77%
- NET PROFIT(Q) At CNY 20.2 MM has Grown at 231.48%
- ROCE(HY) Highest at 7.06%
2
With ROE of 7.74%, it has a attractive valuation with a 2.99 Price to Book Value
Stock DNA
Tour, Travel Related Services
CNY 3,133 Million (Small Cap)
39.00
NA
0.00%
-0.45
9.42%
2.77
Revenue and Profits:
Net Sales:
219 Million
(Quarterly Results - Sep 2025)
Net Profit:
27 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.04%
0%
-15.04%
6 Months
9.44%
0%
9.44%
1 Year
17.1%
0%
17.1%
2 Years
58.04%
0%
58.04%
3 Years
21.18%
0%
21.18%
4 Years
10.51%
0%
10.51%
5 Years
58.6%
0%
58.6%
Youngy Health Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.28%
EBIT Growth (5y)
18.52%
EBIT to Interest (avg)
33.28
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.57
Sales to Capital Employed (avg)
0.60
Tax Ratio
25.24%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.86%
ROE (avg)
5.32%
Valuation key factors
Factor
Value
P/E Ratio
39
Industry P/E
Price to Book Value
2.99
EV to EBIT
27.43
EV to EBITDA
21.32
EV to Capital Employed
6.72
EV to Sales
3.31
PEG Ratio
0.37
Dividend Yield
NA
ROCE (Latest)
24.49%
ROE (Latest)
7.74%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
219.10
142.40
53.86%
Operating Profit (PBDIT) excl Other Income
36.20
15.20
138.16%
Interest
0.00
0.00
Exceptional Items
-1.60
2.10
-176.19%
Consolidate Net Profit
27.30
9.90
175.76%
Operating Profit Margin (Excl OI)
165.40%
54.20%
11.12%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 53.86% vs 38.25% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is 175.76% vs 50.00% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
688.10
528.80
30.12%
Operating Profit (PBDIT) excl Other Income
91.70
61.80
48.38%
Interest
1.00
2.40
-58.33%
Exceptional Items
5.70
14.00
-59.29%
Consolidate Net Profit
66.10
41.90
57.76%
Operating Profit Margin (Excl OI)
91.30%
63.40%
2.79%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 30.12% vs 14.36% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 57.76% vs -68.57% in Dec 2023
About Youngy Health Co., Ltd. 
Youngy Health Co., Ltd.
Tour, Travel Related Services
No Details Available.
Company Coordinates 
No Company Details Available






